LGALS3BP has already been used to build multi‐component classifiers for the prediction of NAFLD (Wood et al, 2017) and fibrosis in patients with hepatitis C infection (Cheung et al, 2010). This evidence concerns the gene LGALS3BP and hepatitis C virus infection.